A new 23-country study by a multidisciplinary team of researchers in the journal Vaccine, published by Elsevier, sheds light on the factors that contribute to COVID-19 vaccine hesitancy among healthcare providers. To...
Findings from the UK’s world-leading human challenge study provide new insights into mild infections with SARS-CoV-2 in healthy young adults. The collaborative study is the first in the world to perform detailed...
The findings of the study were published in the American Journal of Obstetrics and Gynecology MFM. The effectiveness of the Pfizer-BioNTech and Moderna mRNA Covid-19 vaccines, the researchers say, lies in their ability...
Tuberculosis incidence among people aged 50 years or older in the United States is high but declining rapidly within subsequent birth cohorts, according to a study in Clinical Infectious Diseases. As an example, the...
Researchers at ASU’s College of Health Solutions find increase in vaccination exemptions, decrease in herd immunity among Arizona schoolchildren Evidence suggests the use of vaccines goes as far back as the year...
The results of the B Part of It study – the largest meningococcal B herd immunity study ever conducted – are published in the New England Journal of Medicine. The results have implications for all meningococcal B...
An experimental vaccine against the Zika virus reduced the amount of virus in pregnant rhesus macaques and improved fetal outcomes, according to a study published in the journal Science Translational Medicine. The study...
A unique adjuvant, a substance that enhances the body’s immune response to toxins and foreign matter, can prevent vaccine-enhanced respiratory disease, a sickness that has posed a major hurdle in vaccine development for...
South Africa hosts historic NIH-supported clinical trial The first HIV vaccine efficacy study to launch anywhere in seven years is now testing whether an experimental vaccine regimen safely prevents HIV infection among...
Human safety trials are already under way, researchers add. An experimental DNA-based vaccine protected monkeys from infection with the birth defects-causing Zika virus, and it has proceeded to human safety trials...